Towergate has formed a partnership with Cancer
Research UK, the UK's leading charity dedicated to cancer
research.
Cancer Research UK's work saves lives. Our vision is 'together, we
will beat cancer'. Cancer Research fund the work of
3000 scientists, doctors and nurses in hospitals, universities
and research centres in many towns and cities across the UK
including Glasgow, Manchester and London.
Most of us know the statistic that one in three of us will get
cancer at some point in our lives. Most of us know someone who has
had cancer and has perhaps had the support of a local hospice. This
disease has a major impact on everyone connected with it - the
people with cancer, their friends and their family. Together, we
can do something about it.
Cancer Research UK's pioneering research aims to help
prevent, diagnose and treat cancer, and ensure that the findings
are used for everyone's benefit. Seven out of ten children now
survive childhood cancers thanks to research. But that still
leaves three out of ten children needing our help. The work of
Cancer Research UK is funded almost entirely by the general public
with just over half of the fundraising total made up from
individual donations of £50 or less (excluding donations made by
people leaving money through their Will).
The project Towergate is supporting
Towergate Charitable Foundation will be providing significant
funding towards a team of world-class scientists based in Oxford
headed up by Professor Adrian Harris.
Professor Adrian Harris and his team are
carrying out groundbreaking work at the University of Oxford.
Some of their recent discoveries could help doctors tailor
treatment to suit an individual’s cancer, so that in the future
people get the most effective therapy for their disease.
This includes looking at ways to block tumours
from hijacking the blood supply which can then grow and spread
round the body. Most cancer deaths are caused by tumours that
spread. This process – known as metastasis – is what makes cancer
so difficult to treat. Professor Harris’s findings may lead to new
drugs that prevent tumours from forming their own blood
supply. This would starve cancer of the oxygen and nutrients
it needs to survive, and is one of the best chances we have of
stopping the growth and spread of many types of cancer.
Professor Harris is a highly respected figure
in the realm of cancer research, and his work has been funded by
Cancer Research UK for many years. His team publish their
research in a number of scientific journals, sharing it with
scientists and doctors all over the world.
This sharing of knowledge is vital in the
fight against cancer, which is one reason why Cancer Research UK
plays a major role in the National Cancer Research Institute
(NCRI). This is a national body which aims to co-ordinate the
efforts of all organisations in the UK working in the field of
cancer research.
In October 2007, Professor Harris spoke as a
leading cancer expert at the annual NCRI conference, which
attracted leaders in cancer treatment and research from across the
globe.
By supporting Cancer Research UK, you’ll be
helping them make an impact not just in the UK - but across the
world.
Cancer Research UK thanks Team Towergate
- Company, Colleagues and Clients for supporting their
vision that together, we will beat cancer.
 |
Professor Harris is the Cancer Research UK Professor of
Clinical Oncology in the University of Oxford. He is Director of
the Cancer Research UK Molecular Oncology Laboratories at the
Weatherall Institute of Molecular Medicine. |
 |
This picture shows a tumour (stained blue) that has started to
develop its own blood supply (the brown vessels, seen most clearly
on the right). As well as providing oxygen and nutrients for the
tumour to grow, the blood supply also provides a route for
break-away cancer cells to spread to other parts of the body. |
